ADAPTCELL
LIVE

Serial Number

99203293

Owner

Tevogen Bio, Inc.

Attorney

Anna Kurian Shaw

Filing Date

May 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ADAPTCELL Trademark

Serial Number: 99203293

ADAPTCELL is a trademark filed by Tevogen Bio, Inc. on May 27, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Tevogen Bio, Inc.

15 Independence Boulevard, Suite 410
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

May 27, 2025

Registration Date

Not Registered

Published for Opposition

May 19, 2026

Goods & Services

Biomanufacturing for others, namely, custom manufacture of pharmaceuticals in the nature of T cells, using biological materials in the manufacturing process

Scientific research, development, and design of computer software and computer technology in the fields of biotechnology, life sciences, data analysis, protein sequencing, artificial intelligence, and machine learning; computer-aided scientific analysis in the fields of biotechnology, life sciences, data analytics technology, artificial intelligence, and machine learning; computer modelling services in the fields of biotechnology, life sciences, data analysis, protein sequencing, artificial intelligence, and machine learning; scientific research and analysis in the fields of biotechnology, life sciences, data analytics technology, artificial intelligence, and machine learning; providing temporary use of online non-downloadable computer software for machine learning and training of artificial intelligence models in the fields of biomedical, biotechnological, and immunological research; providing temporary use of online non-downloadable computer software for protein sequencing; providing temporary use of online non-downloadable computer software for identification of protein types for scientific research and medical purposes; providing scientific research news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) and machine learning (ML) technology

Providing a website featuring medical news and medical information concerning biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies that utilize artificial intelligence (AI) and machine learning (ML) technology

Compilation of information into computer databases in the fields of biotechnology and life sciences; data compilation services being compilation of business data into computer databases in the field of scientific, chemical, physical, or biological analysis; compilation of information into computer databases in the field of scientific, chemical, physical, or biological analysis; data processing services in the field of scientific, chemical, physical, or biological analysis; data verification services, namely, updating and maintenance of business data in computer databases in the field of scientific, chemical, physical, or biological data; business data analysis services for businesses conducting scientific, chemical, physical, or biological analysis; data processing and business data analysis for businesses generating scientific, chemical, physical, or biological data; database management in the fields of biotechnology and life sciences; database management services, namely, management of databases in the field of scientific, chemical, physical, or biological data; promoting awareness of the benefits of the use of artificial intelligence (AI) and machine learning (ML) technology in the field of biotechnology to expedite drug development, optimize laboratory processes, unravel complex biological data, and improve patient outcomes; promotion and advocacy services, namely promoting awareness of the benefits of the advancement of biomedical, biotechnological, and immunological research and the curing of various diseases utilizing artificial intelligence (AI) and machine learning (ML) technology by means of public advocacy

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 27, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 27, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 27, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 27, 2025 MAFR
NEW APPLICATION ENTERED
May 27, 2025 NWAP